Publications in collaboration with researchers from Novartis (Sweden) (3)

2017

  1. Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator– and Placebo-Controlled Study

    Arthritis and Rheumatology, Vol. 69, Núm. 6, pp. 1144-1153

2001

  1. Removal of bowel aerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural α-Galactosyl IgG antibodies

    Xenotransplantation, Vol. 8, Núm. 1, pp. 15-23

1999

  1. Sustained decrease of serum anti-galactose α1-3-galactose antibodies in baboons by removing aerobic gram-negative bacteria from the bowel

    Transplantation Proceedings